Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,864 | 230 | 99.8% |
| Education | $17.14 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,343 | 55 | $0 (2022) |
| Novo Nordisk Inc | $841.33 | 29 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $733.40 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $540.50 | 17 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $524.71 | 32 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $430.53 | 13 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $319.09 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $306.53 | 7 | $0 (2021) |
| Medtronic Vascular, Inc. | $270.86 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $235.24 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.62 | 1 | AstraZeneca Pharmaceuticals LP ($52.62) |
| 2023 | $295.52 | 3 | AstraZeneca Pharmaceuticals LP ($170.55) |
| 2022 | $697.45 | 15 | Novo Nordisk Inc ($252.38) |
| 2021 | $970.42 | 31 | AstraZeneca Pharmaceuticals LP ($265.37) |
| 2020 | $1,042 | 39 | Amgen Inc. ($268.19) |
| 2019 | $1,209 | 42 | Amgen Inc. ($307.86) |
| 2018 | $1,397 | 39 | Amgen Inc. ($251.95) |
| 2017 | $1,217 | 63 | Amgen Inc. ($186.21) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 4 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Anemia | ||||||
| 06/11/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular | ||||||
| 06/03/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Neuroscience | ||||||
| 05/26/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Neuroscience | ||||||
| 04/16/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Cardiovascular | ||||||
| 04/02/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Neuroscience | ||||||
| 03/09/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: Inflammation | ||||||
| 03/05/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $120.08 | General |
| Category: Anemia | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $63.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Anemia | ||||||
| 01/16/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Neuroscience | ||||||
| 01/02/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Cardiology | ||||||
| 12/11/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Neuroscience | ||||||
| 12/02/2019 | Amgen Inc. | Otezla (Biological) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Inflammation | ||||||
| 11/20/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Neuroscience | ||||||
| 11/14/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Bone Health | ||||||
| 11/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $73.53 | General |
| Category: Cardiovascular | ||||||
| 10/30/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Dermatology | ||||||
| 10/24/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Neuroscience | ||||||
| 10/21/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| Category: Cardiovascular | ||||||
| 10/20/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 111 | 241 | $37,915 | $17,947 |
| 2021 | 2 | 90 | 232 | $38,000 | $19,392 |
| 2020 | 7 | 181 | 319 | $39,369 | $18,363 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 193 | $33,775 | $16,156 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 24 | $3,000 | $1,202 | 40.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $540.00 | $336.54 | 62.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 12 | 12 | $600.00 | $251.96 | 42.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 208 | $35,200 | $18,020 | 51.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 24 | $2,800 | $1,372 | 49.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 213 | $33,015 | $15,448 | 46.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 24 | $2,520 | $1,220 | 48.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 12 | $899.00 | $455.12 | 50.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2020 | 12 | 17 | $510.00 | $439.76 | 86.2% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 16 | 17 | $850.00 | $331.00 | 38.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 17 | $720.00 | $272.55 | 37.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 19 | $855.00 | $196.66 | 23.0% |
About Dr. Augusto Fojas, MD
Dr. Augusto Fojas, MD is a Internal Medicine healthcare provider based in Toronto, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205891710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Augusto Fojas, MD has received a total of $6,881 in payments from pharmaceutical and medical device companies, with $52.62 received in 2024. These payments were reported across 233 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($6,864).
As a Medicare-enrolled provider, Fojas has provided services to 382 Medicare beneficiaries, totaling 792 services with total Medicare billing of $55,702. Data is available for 3 years (2020–2022), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Toronto, OH
- Active Since 04/18/2006
- Last Updated 06/14/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205891710
Products in Payments
- Ozempic (Drug) $506.93
- FARXIGA (Drug) $450.56
- Repatha (Biological) $439.94
- ELIQUIS (Drug) $430.53
- XARELTO (Drug) $397.91
- Aimovig (Biological) $380.57
- Kerendia (Drug) $319.09
- ENTRESTO (Drug) $306.53
- Otezla (Drug) $285.34
- Prolia (Biological) $266.26
- STEGLATRO (Drug) $249.76
- INJECTAFER (Drug) $235.24
- Victoza (Drug) $207.80
- NUEDEXTA (Drug) $196.79
- JANUVIA (Drug) $185.36
- BREZTRI (Drug) $178.23
- JARDIANCE (Drug) $150.39
- INVOKANA (Drug) $142.59
- Vascepa (Drug) $127.43
- Aptus Heli-FX (Device) $126.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Toronto
Marc Monachese
Internal Medicine — Payments: $34,588
Francisco Lopez, M.d, M.D
Internal Medicine — Payments: $16,537
Edward Lynch, Md, MD
Internal Medicine
Dr. Betty Chan, Md, MD
Internal Medicine
Dr. Khalil Sivjee, Md, MD
Internal Medicine